Literature DB >> 24882571

Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media.

Yu Si1, Zhi Gang Zhang2, Sui Jun Chen1, Yi Qing Zheng1, Yu Bin Chen1, Yi Liu1, Huaili Jiang1, Lian Qiang Feng3, Xi Huang4.   

Abstract

The variability in the recovery of otitis media (OM) is not well understood. Recent data have shown a critical role for toll-like receptors (TLRs) in inflammatory responses to bacteria. It remains unclear whether TLRs-mediated mucosal immunity plays a role in the OM recovery. The etiology, pathological profile, expression levels of TLR2, TLR4, TLR5, TLR9 and proinflammatory cytokines were measured in human middle-ear mucosae sampled from three subject groups: non-OM group, chronic otitis-media (COM) group, and chronic suppurative otitis-media (CSOM) group. Of the 72 ears, 86.11% CSOM patients were positive for bacteria. The cellular makeup of the middle ear mucosa differs among the three groups. Mucosae from the CSOM group presented chronic inflammation or suppurative inflammation in the rudimentary stroma, mainly with infiltration of monocytes and macrophages. The mRNA and protein levels of TLR2, TLR4, and TLR5 exhibited no difference between the non-OM and COM groups but were significantly lower in the CSOM group. Conversely, there was no significant difference in the TLR9 level among the three groups. Furthermore, proinflammatory cytokines TNF-α, IL-1β, IFN-γ, IL-6 were up-regulated in the CSOM group. This study provides evidence that the variability in clinical otitis media recovery might be associated with the variability in the expression of mucosal TLRs. Reduced TLR levels in the middle-ear mucosa might cause weak host response to bacteria, persistent inflammation and susceptibility to CSOM.
Copyright © 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Otitis media; Recovery; TLR

Mesh:

Substances:

Year:  2014        PMID: 24882571     DOI: 10.1016/j.humimm.2014.05.009

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  15 in total

1.  Otitis media induced by peptidoglycan-polysaccharide (PGPS) in TLR2-deficient (Tlr2(-/-)) mice for developing drug therapy.

Authors:  Xiaolin Zhang; Tihua Zheng; Lu Sang; Luke Apisa; Hongchun Zhao; Fenghua Fu; Qingzhu Wang; Yanfei Wang; Qingyin Zheng
Journal:  Infect Genet Evol       Date:  2015-08-18       Impact factor: 3.342

Review 2.  Role of innate immunity in the pathogenesis of otitis media.

Authors:  Rahul Mittal; Joyson Kodiyan; Robert Gerring; Kalai Mathee; Jian-Dong Li; M'hamed Grati; Xue Zhong Liu
Journal:  Int J Infect Dis       Date:  2014-11-05       Impact factor: 3.623

Review 3.  Panel 3: Genetics and Precision Medicine of Otitis Media.

Authors:  Jizhen Lin; Lena Hafrén; Joseph Kerschner; Jian-Dong Li; Steve Brown; Qing Y Zheng; Diego Preciado; Yoshihisa Nakamura; Qiuhong Huang; Yan Zhang
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

Review 4.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

Review 5.  Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.

Authors:  Arwa Kurabi; Kwang Pak; Allen F Ryan; Stephen I Wasserman
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 6.  [The role of innate immunity in otitis media].

Authors:  M Wigand; T K Hoffmann; A F Ryan; B Wollenberg; A Leichtle
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

Review 7.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

8.  High-mobility group box protein 1 expression in inflammatory diseases of the middle ear.

Authors:  Luisa Maria Bellussi; Carla Vindigni; Serena Cocca; Marie Aimee Gloria Munezero Butorano; Walter Livi; Giulia Corallo; Desiderio Passali
Journal:  Int J Immunopathol Pharmacol       Date:  2017-03-15       Impact factor: 3.219

Review 9.  Subversion of host immune responses by otopathogens during otitis media.

Authors:  James M Parrish; Manasi Soni; Rahul Mittal
Journal:  J Leukoc Biol       Date:  2019-05-10       Impact factor: 4.962

Review 10.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.